PANCREATIC TOXICITY AS AN ADVERSE EFFECT INDUCED BY MEGLUMINE ANTIMONIATE THERAPY IN A CLINICAL TRIAL FOR CUTANEOUS LEISHMANIASIS

PANCREATIC TOXICITY AS AN ADVERSE EFFECT INDUCED BY MEGLUMINE ANTIMONIATE THERAPY IN A CLINICAL TRIAL FOR CUTANEOUS LEISHMANIASIS

SUMMARY American tegumentary leishmaniasis is an infectious disease caused by a protozoan of the genus Leishmania. Pentavalent antimonials are the first choice drugs for cutaneous leishmaniasis (CL), although doses are controversial. In a clinical trial for CL we investigated the occurrence of panc...

Full description

Bibliographic Details
Main Authors: Marcelo Rosandiski LYRA, Sonia Regina Lambert PASSOS, Maria Inês Fernandes PIMENTEL, Sandro Javier BEDOYA-PACHECO, Cláudia Maria VALETE-ROSALINO, Erica Camargo Ferreira VASCONCELLOS, Liliane Fatima ANTONIO, Mauricio Naoto SAHEKI, Mariza Mattos SALGUEIRO, Ginelza Peres Lima SANTOS, Madelon Noato RIBEIRO, Fatima CONCEIÇÃO-SILVA, Maria Fatima MADEIRA, Jorge Luiz Nunes SILVA, Aline FAGUNDES, Armando Oliveria SCHUBACH
Format: Article
Language:English
Published: Universidade de São Paulo
Series:Revista do Instituto de Medicina Tropical de São Paulo
Subjects:
Cutaneous leishmaniasis
Therapy
Clinical trial
Meglumine antimoniate
Pancreatitis
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652016005000252&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652016005000252&lng=en&tlng=en

Similar Items